214 related articles for article (PubMed ID: 24846886)
1. [CME myelodysplasia - a frequent hematologic neoplasia in the elderly].
Schleiffenbaum BE
Praxis (Bern 1994); 2014 May; 103(11):617-27. PubMed ID: 24846886
[No Abstract] [Full Text] [Related]
2. 5-Aza-2'-deoxycytidine as a differentiation inducer in acute myeloid leukaemias and myelodysplastic syndromes of the elderly.
Pinto A; Zagonel V; Attadia V; Bullian PL; Gattei V; Carbone A; Monfardini S; Colombatti A
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():28-32. PubMed ID: 2483349
[No Abstract] [Full Text] [Related]
3. More is better: combination therapies for myelodysplastic syndromes.
Ornstein MC; Mukherjee S; Sekeres MA
Best Pract Res Clin Haematol; 2015 Mar; 28(1):22-31. PubMed ID: 25659727
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow leukaemic transformation of myelodysplastic syndrome revealed by a cutaneous Langerhans cell infiltrate: partial response to azacitidine.
Osio A; Elfatoiki F; Raffoux E; Vignon-Pennamen MD; de Labarthe A; Cordoliani F; Petrella T; Bagot M; Janin A; Battistella M; Bouaziz JD
Eur J Dermatol; 2013; 23(5):710-1. PubMed ID: 24125873
[No Abstract] [Full Text] [Related]
5. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
Varma N; Varma S; Marwaha N; Garewal G
Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
[TBL] [Abstract][Full Text] [Related]
6. [Myelodysplastic syndrome--its natural history, clinical course and diagnosis].
Weryńska B
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):867-71. PubMed ID: 2487939
[No Abstract] [Full Text] [Related]
7. [Differential diagnosis between aplastic anemia and hypoplastic myelodysplastic syndromes: from the viewpoint of pediatrics].
Hama A; Ito M; Kojima S
Rinsho Ketsueki; 2012 Oct; 53(10):1485-91. PubMed ID: 23037720
[No Abstract] [Full Text] [Related]
8. Acute myeloid leukemia with myelodysplasia-related changes showing basophilic differentiation.
Wells R; Williams B; Bain BJ
Am J Hematol; 2014 Nov; 89(11):1082. PubMed ID: 24941894
[No Abstract] [Full Text] [Related]
9. The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP).
Malcovati L; Cazzola M
Hematology Am Soc Hematol Educ Program; 2015; 2015():299-307. PubMed ID: 26637737
[TBL] [Abstract][Full Text] [Related]
10. [Current treatment options for myelodysplastic syndromes].
Nolte F; Hofmann WK
Dtsch Med Wochenschr; 2010 Sep; 135(38):1863-9. PubMed ID: 20842606
[No Abstract] [Full Text] [Related]
11. Myelodysplastic syndromes (MDS).
Klimek V
Best Pract Res Clin Haematol; 2015 Mar; 28(1):1-2. PubMed ID: 25659724
[No Abstract] [Full Text] [Related]
12. [Aplastic anemia and myelodysplasia: a not-always-easy distinction].
Sardeo G; Gaion F; Artusi T; Dalla Pria AF; Romano G; Puglisi A
Minerva Med; 1987 Oct; 78(20):1519-22. PubMed ID: 3670695
[TBL] [Abstract][Full Text] [Related]
13. [Myelodysplastic syndromes--an overview for the practitioner].
Solenthaler M; Tobler A
Ther Umsch; 2004 Feb; 61(2):117-24. PubMed ID: 15018394
[TBL] [Abstract][Full Text] [Related]
14. [Myelodysplastic syndrome--a retrospective study of 38 patients].
Schrappe-Bächer M; Steffen HM; Maier M; Bernards P; Hoeffken A; Fätkenheuer G
Med Klin (Munich); 1990 Sep; 85(9):511-6. PubMed ID: 2233608
[TBL] [Abstract][Full Text] [Related]
15. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, classification, and course of myelodysplastic syndromes.
McKenna RW; Allison PM
Clin Lab Med; 1990 Dec; 10(4):683-706. PubMed ID: 2272170
[TBL] [Abstract][Full Text] [Related]
17. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
Rosati S; Anastasi J; Vardiman J
Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
[No Abstract] [Full Text] [Related]
18. [Molecular biology in myelodysplastic syndromes and acute myeloid leukemias "smoldering"].
Martinelli G; Sartor C; Papayannidis C; Iacobucci I; Paolini S; Clissa C; Ottaviani E; Finelli C
Recenti Prog Med; 2014 Mar; 105(3):118-22. PubMed ID: 24675454
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplasia: clinical and morphological aspects and treatment.
Geary CG
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():138-40. PubMed ID: 2653491
[No Abstract] [Full Text] [Related]
20. Quantification of marrow CD34+ cells: An important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia.
Orazi A
Leukemia; 2006 Nov; 20(11):2041; author reply 2041-2. PubMed ID: 16990766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
